A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery
A Phase II Study Of A Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus
CALGB 9781: A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, And Surgery) To Surgery Alone For Esophageal Cancer
A Phase III Intergroup Randomized Comparison Of Combined Modality Therapy For Carcinoma Of The Esophagus: High Dose Vs. Conventional Dose Radiation Therapy